Evidence map›Paper›PMID 40317005›Full record

ArticleCell communication and signaling : CCS2025

Transmembrane thiol isomerase TMX1 inhibits fibrin formation by down-regulation of platelet phosphatidylserine exposure.

Zhenzhen Zhao, Yaqiong Zhang, Yixin Cheng, Xuyang Chen, Yi Lu, Yue Han, Yi Wu, Aizhen Yang

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Platelet effector functions in inflammation.Research and practice in thrombosis and haemostasis · 2026
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhenzhen Zhao *Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, The Second Affiliated Hospital of Soochow University, Suzhou, China. zhaozhenican@126.com.
Yaqiong Zhang *Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yixin ChengCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Xuyang ChenCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yi LuHunan Sinozex Biosciences Co, Ltd, Changsha, China.
Yue HanInstitute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China.
Yi WuCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, The Second Affiliated Hospital of Soochow University, Suzhou, China. wuy@suda.edu.cn.
Aizhen YangCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, The Second Affiliated Hospital of Soochow University, Suzhou, China. yangaizhen@suda.edu.cn.

Funding

National Natural Science Foundation of China 81970128, 82200147, 82470132, 82170129, 81770138, 31970890, 82270136, 82020108003, 82330008the China Postdoctoral Science Foundation 2021TQ0231, 2022M722322the collaboration fund from State Key Laboratory of Radiation Medicine and Protection GZN1201802the Jiangsu Provincial Medical Innovation Center CXZX202201the Translational Research Grant of NCRCH 2020ZKPA02, 2020WSA04
6 · The paper itself

Abstract

objectiveMembrane exposure of phosphatidylserine (PS) on platelets is critical for the binding of coagulation factors leading to coagulation activation, however, the mechanism controlling PS exposure remains largely unknown. Using genetically modified mouse models, we previously reported that a transmembrane disulfide isomerase TMX1 inhibited integrin αIIbβ3 outside-in signaling which is important for PS exposure on platelets. In this study, we investigated the role of TMX1 in PS exposure and coagulation. APPROACH AND

resultsWe found that the deficiency of TMX1 in platelets enhanced fibrin formation and PS exposure at the site of injury. In vitro, TMX1 inhibited thrombin generation mediated by activated platelets, and attenuated PS exposure on platelets, the effect of which was prevented when integrin αIIbβ3 outside-in signaling was blocked, suggesting that TMX1 inhibition of integrin αIIbβ3 outside-in signaling suppresses PS exposure. Moreover, TMX1 deficiency increased the free thiols of TMEM16 F in platelets including Cys338, Cys349 and Cys352. In HEK293 T cells overexpressing C338S-, C349S-mutated TMEM16 F, the PS exposure was increased, suggesting that TMX1 oxidizes these disulfide bonds of TMEM16 F, decreasing its activity to externalize PS on the membrane.

conclusionTogether, our observations for the first time demonstrate that TMX1 inhibits PS exposure in platelets downregulating the procoagulant activity, by which TMX1 plays a critical role in maintaining vascular quiescence.

Indexed as

Blood PlateletsDown-RegulationFibrinMembrane ProteinsPhosphatidylserinesProtein Disulfide-IsomerasesAnimalsBlood CoagulationHEK293 CellsHumansMicePlatelet Glycoprotein GPIIb-IIIa ComplexThrombinFibrinMembrane ProteinsPhosphatidylserinesPlatelet Glycoprotein GPIIb-IIIa ComplexProtein Disulfide-IsomerasesThrombinPhosphatidylserinePlateletRedoxThiol isomeraseThrombosis

Identifiers

PMID40317005
PMCPMC12048996

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.